To further explore and validate the association between IL-6 and the progranulin–sortilin axis in breast cancer, we analyzed the gene expression of associated gene markers in cancer cells grown in an in vivo-like 3D growth system using patient-derived scaffolds (PDS) and compared the results with 2D monocultures [23]. This evidence concerns the gene GRN and breast cancer.